TCT 919: Lifetime managemnt of calcified congenital bicuspid aortic valve and left atrial appendage occlusion in a Jehovah's witness patient with ongoing bleeding Receive the the latest news, research ...

Transcatheter aortic valve replacement (TAVR) is valve replacement without open-heart surgery. It is also called catheter-based or percutaneous (through the skin) aortic valve replacement.

Delayed Cardiac Arrest After On-Pump Transcatheter Valve Trans-septal Mitral Valve-in-Valve Replacement Combined With Alcohol Septal Ablation to Relieve Left Ventricular Outflow Tract Obstruction: A ...

The global transcatheter aortic valve replacement market size is expected to reach USD 10.2 billion by 2030, expanding at 7.2% CAGR from 2023 to 2030.

For patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from ra ...

Conclusions In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke.

In patients with severe aortic stenosis, transfemoral transcatheter aortic valve replacement with a repositionable valve appears to yield a high rate of device success, no moderate or severe ...

The Company is in clinical development of its next generation transfemoral TAVR system in both the U.S. and CE Mark countries for treating patients with aortic stenosis and/or aortic regurgitation.

The transfemoral catheter is designed to deliver the bioprosthesis using a simple stepped approach to achieve anatomical positioning within the native valve.

Medtronic, the global leader in healthcare technology, today announced new data from the largest head-to-head comparative trial of transfemoral transcatheter aortic valve replacement (TAVR), the ...

CoreValve’s transcatheter, transfemoral aortic valve replacement product is a non-surgical alternative that offers the large number of high or prohibitive surgical-risk patients an opportunity ...